A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

This study is testing a new combination pill that addresses both type 2 diabetes and high blood pressure at the same time. Researchers want to know if taking three medications together (dapagliflozin, telmisartan, and metformin) works better than existing two-drug combos. **You may be eligible if...** - You are 19 or older - You have type 2 diabetes AND high blood pressure - Your HbA1c (average blood sugar) is between 6.5% and 9.5% - Your blood sugar (fasting) is 270 mg/dL or below - Your systolic blood pressure is between 140 and 160 mmHg - You are currently on metformin alone or not on diabetes medication **You may NOT be eligible if...** - Your BMI is over 35 - You have moderate to severe kidney problems - You have serious heart conditions (heart failure class III/IV, recent heart attack, or unstable angina within the past 6 months) - You had a stroke within the past 6 months - You are pregnant or breastfeeding - You have liver disease or elevated liver enzymes Talk to your doctor to see if this trial is right for you.